Recent Quotes (30 days)

You have no recent quotes
chg | %

Glenmark Pharmaceuticals Ltd  

(Public, BOM:532296)   Watch this stock  
Find more results for 532296
609.50
-1.40 (-0.23%)
Oct 19 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 604.20 - 611.80
52 week 567.95 - 993.00
Open 611.00
Vol. 37,638.00
Mkt cap 171.90B
P/E 14.14
Div/yield 2.00/0.33
EPS 43.09
Shares 0.00
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 18.14% 9.18%
Operating margin 27.07% 15.21%
EBITD margin - 18.73%
Return on average assets - 6.77%
Return on average equity - 19.31%
Employees 10,025 -
CDP Score - -

Address

B D S Marg Chakala, Off Western Express Highway Andheri (E),
MUMBAI, 400099
India
+91-22-40189999 (Phone)
+91-22-40189986 (Fax)

Website links

Description

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada. Its products are primarily marketed in the United States and Western Europe. It has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.

Officers and directors

Glenn Mario Saldanha Executive Chairman of the Board, Chief Executive Officer, Managing Director
Age: 46
P. Ganesh President, Chief Financial Officer
Harish Kuber Compliance Officer, Company Secretary
Murali Neelakantan Executive Director - Global General Counsel, Executive Director
Cherylann Pinto Whole-Time Director
Rajesh V. Desai Non-Executive Director
Age: 52
Blanche E. Saldanha Non-Executive Director
Sridhar Gorthi Non-Executive Independent Director
Age: 43
Devendra Raj Mehta Non-Executive Independent Director
Age: 79
Bernard Munos Non-Executive Independent Director